Archives

by in
Entry Author Date Location
NanoString Technologies Maneuvers In Line for $86M IPO 05/20/13 Seattle
Blaze Bioscience Caps Off $8.5M Financing, Charges Toward Clinic 02/22/13 Seattle
The Intersection of the Double Helix and Life Sciences in Seattle 01/22/13 Seattle
How To Build a Biotech Cluster That Isn’t Boston or SF 11/20/12 National
Novo Nordisk Weaves Itself Into Seattle Biotech, With Diabetes R&D 07/06/12 Seattle
How Biogen Idec Overhauled R&D Under Doug Williams 03/07/12 Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News 10/20/11 Seattle
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors 10/18/11 Seattle
How Seattle Set Out to Create a Biotech Hub and Fostered a Global Health Nexus 08/08/11 Seattle
The Missing Ingredient in Today’s Biotech: Guts 07/11/11 National
Editor’s Picks: Xconomy Seattle’s Top Stories of the First Quarter 03/31/11 Seattle
Dendreon Makes It Official, Grabs Downtown Office and Former Zymo Lab Building 03/01/11 Seattle
Washington’s Innovation Corridor a Key to Recovery 02/18/11 Seattle
Seattle Genetics Manager Accused of Insider Trading, Bristol Stays in Seattle, Amgen Buys BioVex, & More Seattle-Area Life Sciences News 01/27/11 Seattle
Bristol-Myers Squibb to Stay in Seattle, Keep ZymoGenetics Workers 01/25/11 Seattle
How ZymoGenetics Coulda Been a Contender: The Big Break That Came Too Late 01/25/11 Seattle
Dendreon’s European Plan, Williams Heads East, Allozyne Passes Clinical Trial, & More Seattle-Area Life Sciences News 01/13/11 Seattle
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
Biogen Idec’s New R&D Boss, Doug Williams, Spurns Corner Office for a Return to Big Science 01/06/11 Boston
Biogen Idec Nabs Doug Williams as R&D Head, Steve Holtzman as BD Chief To Fill Out Management Team 01/05/11 Boston
Editor’s Picks: The Best of 2010 From Xconomy Seattle 12/23/10 Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News 11/11/10 Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech 11/09/10 Seattle
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster 10/26/10 Seattle
Intellectual Ventures’ Latest Big Push: Turning Med-Tech Inventions Into Cash 10/18/10 Seattle
Seattle Genetics Nails 2nd Trial, Bristol Clinches Zymo Buyout, Halosource Goes Public, & More Seattle-Area Life Sciences News 10/14/10 Seattle
Bristol-Myers Almost Ready to Seal the Deal, Complete Takeover of ZymoGenetics 10/08/10 Seattle
Embryonic Stem Cell Research Foe, Tracy Deisher, Seeks to Market Pro-Life Vaccines 10/01/10 Seattle
Page 1 of 6 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.